{"id":35940,"date":"2025-06-20T18:10:04","date_gmt":"2025-06-20T18:10:04","guid":{"rendered":"https:\/\/todaysveterinarypractice.com\/?p=35940"},"modified":"2025-06-26T19:31:07","modified_gmt":"2025-06-26T19:31:07","slug":"5-tips-for-managing-canine-allergies-with-zenrelia-ilunocitinib-tablets","status":"publish","type":"post","link":"https:\/\/navc.sitepreview.app\/todaysveterinarypractice.com\/sponsored\/5-tips-for-managing-canine-allergies-with-zenrelia-ilunocitinib-tablets\/","title":{"rendered":"5 Tips for Managing Canine Allergies With Zenrelia\u2122 (ilunocitinib tablets)"},"content":{"rendered":"

Zenrelia\u2122 (ilunocitinib tablets) offers veterinarians an option to relieve itching and inflammation in their canine patients. Andrew Rosenberg, DVM, DACVD, shares 5 key tips for integrating Zenrelia into your allergy management toolbox. Listen to the full Vet2Vet conversation below between Dr. Rosenberg and Cassi Fleming, MS, DVM.<\/span><\/p>\n

\n

Brought to you by Elanco Animal Health\u00a0 <\/span><\/span>\u2022<\/span>\u00a0 <\/span><\/span>ZenreliaForVets.com<\/span><\/a><\/p>\n

\n

1. Think Beyond the Clinical Signs<\/b><\/span>
\nWhen a dog is severely itchy, everything suffers, including sleep, comfort and the human-animal bond. Using Zenrelia controls the itch, making it easier for families to reconnect and enjoy everyday life together.<\/span><\/p>\n

2. Emphasize Simple Dosing<\/b><\/span>
\nOnce-daily dosing, without a need for loading or tapering, sets Zenrelia apart from other Janus kinase inhibitors. Simple and clear once daily dosing that does not change over time can help improve compliance.<\/span><\/p>\n

3. Plan Around Vaccinations<\/b><\/span>
\nZenrelia affects the immune response, so it should not be given to patients concurrently with any vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. <\/span><\/p>\n

4. Highlight Individual Differences<\/b><\/span>
\nNot all allergy patients are the same, even if they have similar clinical presentations. Each dog\u2019s cytokine profile is unique, meaning it will respond differently to various therapies. Some patients who have failed similar therapies have had success with Zenrelia.
\n<\/span><\/p>\n

5. Monitor Success Comprehensively<\/b><\/span>
\nAsk pet owners to monitor their pet\u2019s quality of life rather than focusing only on the skin\u2019s appearance. Improved sleep, reduced scratching, and better overall comfort are also important indicators of successful therapy. Objective tools like the pruritus visual analog scale (PVAS) can help clients track progress over time.<\/span><\/p>\n